Don M. Benson

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

Don M. Benson, Courtney E. Bakan, Anjali Mishra et al. · Blood · 2010 · 797 citations · Full text

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia

Jennifer R. Brown, John C. Byrd, Steven Coutré et al. · Blood · 2014 · 583 citations · Full text

RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development

Flavia Pichiorri, Sung-Suk Suh, Alberto Rocci et al. · Cancer Cell · 2010 · 443 citations · Full text

Hematological Malignancy, Tumor Biology, P53/mdm2 Autoregulatory Loop +8

Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells

François Romagné, Pascale André, Pieter Spee et al. · Blood · 2009 · 388 citations · Full text

Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC

Shauna M. Collins, Courtney E. Bakan, Gina D. Swartzel et al. · Cancer Immunology Immunotherapy · 2013 · 291 citations · Full text

Hematological Malignancy, Cancer Immunosurveillance, Immunology +6